Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000025

CEO bought 55,000 shares at an average $0.01 ($646)

  • CEO bought 2,000 shares at $0.01 ($27)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-25 Purchase : show line 1 in the form −2,000 $0.01 $27 21,061,123 D
2019-04-25 Purchase : show line 2 in the form +2,000 $0.01 $23 21,063,123 D
2019-04-25 Purchase : show line 3 in the form +10,000 $0.01 $117 21,073,123 D
2019-04-25 Purchase : show line 4 in the form +5,000 $0.01 $61 21,078,123 D
2019-04-25 Purchase : show line 5 in the form +2,000 $0.01 $25 21,080,123 D
2019-04-25 Purchase : show line 6 in the form +5,000 $0.01 $62 21,085,123 D
2019-04-25 Purchase : show line 7 in the form +2,000 $0.01 $24 21,087,123 D
2019-04-25 Purchase : show line 8 in the form +2,000 $0.01 $23 21,089,123 D
Open-market purchases · 57,000 sh · avg $0.01 · $673
Loading xslF345X03/primary_doc.xml…